Bay Street News, 2024

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the […]

Glass Lewis & Co. has recommended unitholders of the REIT vote in favour of plan of arrangement with Melcor Developments […]

Toronto, ON, Nov. 15, 2024 (GLOBE NEWSWIRE) — Gulf & Pacific Equities Corp. (TSX-V: GUF) an established company focused on […]

– Continued execution across Ampligen® clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer […]

Ms. Connell is a commercial executive with business development expertise Appointment takes place as Opthea prepares for Phase 3 wet […]

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented […]

A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year […]

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the […]

DUBAI, United Arab Emirates, Nov. 15, 2024 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a […]

LAS VEGAS, Nov. 15, 2024 (GLOBE NEWSWIRE) — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data,” or […]